Global Strategic Alliance & MSA with Image Analysis Group
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Resonance Health Ltd has announced a strategic alliance and master services agreement with Image Analysis Group, a global imaging clinical research organization, to enhance their clinical trial capabilities. The agreement allows Resonance's MRI analysis services to be integrated into IAG's global clinical trial strategies, providing access to a broader imaging infrastructure. This partnership targets high-growth areas such as obesity and metabolic diseases, with a focus on non-invasive imaging technologies. The agreement is non-exclusive and includes an initial term with options for renewal, with revenue dependent on executed work orders.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Resonance Health
- FY26 Full Year Results & Investor Webinar
- Liver Fibrosis Device Progress & FY26 Portfolio Webinar
- Profit Guidance Upgrade
- Receipt of R&D Tax Incentive Refund
- Half Year Results Presentation
Later from Resonance Health
- Trading Halt
- Liver Fibrosis Device - EPoC Study Results
- $6.0 Million Placement Oversubscribed
- Investor Presentation Liver Fibrosis Device & Capital Raise
- Liver Fibrosis Device Webinar Presentation
Follow Resonance Health into a list and get an email when it puts out news.
Follow Resonance Health